AUTHOREA
Log in
Sign Up
Browse Preprints
LOG IN
SIGN UP
Please note
: Importing new articles from Word documents is currently unavailable. We are working on fixing this issue soon and apologize for any inconvenience.
Agaath Hedina Manickam
Public Documents
1
Raynaud's phenomenon secondary to erenumab in a patient with chronic migraine
Agaath Hedina Manickam
and 3 more
April 06, 2021
The case of a 45 year old female with chronic migraine undergoing treatment with erenumab 70 mg subcutaneous injection who developed Raynaud’s phenomenon (RP) as a side effect with relevant clinical implications two weeks after the second dose of erenumab injection.